| Influenza |
1 |
1 |
| Influenza Vaccine |
0 |
0.78 |
| Coronary Artery Disease (CAD) |
0 |
0.98 |
| Cardiovascular disease |
0 |
0.97 |
| Immunization |
0 |
0.54 |
| Cardiovascular Risk Management |
0 |
0.42 |
| Artery |
0 |
0.24 |
| Acute Myocardial Infarction (MI) |
0 |
0.2 |
| Anticoagulation Therapy |
0 |
0.18 |
| Myocardial Infarction (MI) |
0 |
0.99 |
| Acute Coronary Syndrome |
0 |
0.13 |
| Canada |
0 |
0.12 |
| Infarction |
0 |
0.12 |
| Vaccines |
0 |
0.09 |
| Allergy |
0 |
0.06 |
| Blood |
0 |
0.06 |
| Clinical Guidelines |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Infection Control |
0 |
0.06 |
| Maryland |
0 |
0.06 |
| Polymerase Chain Reaction |
0 |
0.06 |
| Prophylaxis |
0 |
0.06 |
| Statins |
0 |
0.06 |
| Surgery |
0 |
0.06 |